scispace - formally typeset
X

Xiaowen Liu

Researcher at Beth Israel Deaconess Medical Center

Publications -  57
Citations -  1730

Xiaowen Liu is an academic researcher from Beth Israel Deaconess Medical Center. The author has contributed to research in topics: Placebo & Thiamine. The author has an hindex of 22, co-authored 51 publications receiving 1454 citations. Previous affiliations of Xiaowen Liu include Harvard University & University of Wisconsin-Madison.

Papers
More filters
Journal ArticleDOI

Leptin is an effective treatment for hypothalamic amenorrhea

TL;DR: A randomized, double-blinded, placebo-controlled trial of human recombinant leptin (metreleptin) in replacement doses in women with HA resulted in recovery of menstruation and corrected the abnormalities in the gonadal, thyroid, growth hormone, and adrenal axes.
Journal ArticleDOI

Efficacy of metreleptin in obese patients with type 2 diabetes: Cellular and molecular pathways underlying leptin tolerance

TL;DR: In obese patients with diabetes, metreleptin administration did not alter body weight or circulating inflammatory markers but reduced HbA1c marginally, and it was observed for the first time that endoplasmic reticulum (ER) stress in human primary adipocytes inhibits leptin signaling.
Journal ArticleDOI

Salutary effects of adiponectin on colon cancer: in vivo and in vitro studies in mice

TL;DR: Evidence is provided for an important role of adiponectin in colon cancer and mechanistic and pathophysiology studies indicate that adiponECTin or analogues might be useful agents in the management or chemoprevention of colon cancer.
Journal ArticleDOI

Walnut consumption increases satiation but has no effect on insulin resistance or the metabolic profile over a 4-day period.

TL;DR: Walnut consumption over 4 days increased satiety by day 3, and long‐term studies are needed to confirm the physiologic role of walnuts, the duration of time needed for these effects to occur, and to elucidate the underlying mechanisms.